Records containing: Obese
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-28A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of CT-868 Administered for 16 Weeks to Overweight and Obese Adult Participants With Type 1 Diabetes Mellitus
-
CLINICAL_TRIALS study results posted · 2026-07-17A Multiple-Dose Study to Investigate the Bioequivalence of Orforglipron (LY3502970) Capsules and Orforglipron Tablets in Participants With Obesity or Overweight Who Are Otherwise Healthy.
-
CLINICAL_TRIALS study results posted · 2026-07-10A Multiple Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Tablet and Capsule Formulations of LY3502970 in Healthy Overweight and Obese Participants
-
CLINICAL_TRIALS study record update · 2026-04-27A Phase 2, Randomized, Double-blind, Placebo-controlled, Study of the Safety and Tolerability of Aleniglipron in Adult Participants With Type 2 Diabetes Mellitus Living With Obesity or Overweight
-
CLINICAL_TRIALS study record update · 2026-04-13Single-centre Study Investigating the Role of Long-acting Subcutaneous Glucose-dependent Insulinotropic Polypeptide Receptor Agonist (GIP RA) in Combination With Long-acting Subcutaneous Amylin Receptor Agonist on Gastrointestinal Tolerability in Participants With Overweight or Obesity
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-08A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Obese or Overweight Subjects Without Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2026-03-30Examining the Utility of GLP-1 Agonists as Neuroprotective Agents Through a Pilot Clinical Trial in High Risk Population With Neurocognitive Deficits and Obesity
-
CLINICAL_TRIALS study record update · 2026-03-18A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SA030 Injection in Overweight or Obese Participants
-
CLINICAL_TRIALS study record update · 2026-03-10Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men
-
CLINICAL_TRIALS study record update · 2026-03-05A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple-Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RAY1225
-
CLINICAL_TRIALS study record update · 2026-03-02Use of Sedation-Free Transnasal Endoscopy to Improve Access and Lower Costs of Endoscopic Evaluations in a Bariatric Medical and Surgical Program
-
CLINICAL_TRIALS study record update · 2026-02-25A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM17321 in Healthy Adult Participants
-
CLINICAL_TRIALS study record update · 2026-02-10A Phase 2, Randomized, Double-blind, Placebo-controlled, Study of the Safety and Tolerability of Aleniglipron in Adult Participants With Type 2 Diabetes Mellitus Living With Obesity or Overweight
-
CLINICAL_TRIALS study record update · 2026-01-29Olive Oil Polyphenols and Cardiovascular Health Biomarkers
-
CLINICAL_TRIALS study record update · 2026-01-26Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
-
CLINICAL_TRIALS study record update · 2026-01-26A Randomized, Double-blind, Placebo-controlled, Parallel Clinical Trial to Investigate the Safety and Efficacy of MB-1 on Metabolic Health in Overweight and Obese Adults
-
CLINICAL_TRIALS study record update · 2025-12-29Nutritional and Psychocomportemental Reeducation, Sleep Apnea and Comorbidities in Overweight and Obese Subjects
-
CLINICAL_TRIALS study record update · 2025-12-26Effect of Increased Oxytocin Doses on the Mode of Delivery in Obese Primiparous Women With Spontaneous or Induced Labour. A Double-blind, Randomised, Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-12-10Body Fat Reducing Effect and Safety of Enzymatically Modified Isoquercitrin in Overweight and Obese Subjects
-
CLINICAL_TRIALS study record update · 2025-11-21A Mass Balance Study of [14C] GZR18 in Chinese Overweight or Obese Male Subjects
-
CLINICAL_TRIALS study record update · 2025-11-19The Interest of the ANI in the Monitoring of Peroperative Analgesia in Bariatric Surgery: a Randomized Single Blind Study.
-
CLINICAL_TRIALS study record update · 2025-10-20Morning Nutrition and Cognitive Function in Preadolescents
-
CLINICAL_TRIALS study record update · 2025-09-18Pharmacodynamics and Pharmacokinetics of Different Coated and Uncoated Formulations of Glucose Beads After Single and Multiple Dose Administration Under Fasting Conditions in Obese Healthy Subjects
-
CLINICAL_TRIALS study record update · 2025-09-16Study of Metabolic Associated Fatty Liver Disease (MAFLD) and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B Patients
-
CLINICAL_TRIALS study record update · 2025-09-10Dietary Sugar Hyper-absorptive Intestinal Phenotype as a Predictor of Weight Loss Post-bariatric Surgery